Credit Suisse’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,700,000
| Closed | -$2.22M | – | 3128 |
|
|
2023
Q3 | $2.22M | Hold |
3,700,000
| – | – | ﹤0.01% | 1760 |
|
|
2023
Q2 | $4.81M | Sell |
3,700,000
-119,113
| -3% | -$155K | ﹤0.01% | 1353 |
|
|
2023
Q1 | $6.72M | Buy |
3,819,113
+10,967
| +0.3% | +$19.3K | 0.01% | 1116 |
|
|
2022
Q4 | $12M | Buy |
3,808,146
+5,019
| +0.1% | +$15.8K | 0.01% | 846 |
|
|
2022
Q3 | $18.6M | Buy |
3,803,127
+9,827
| +0.3% | +$48.2K | 0.02% | 666 |
|
|
2022
Q2 | $15.7M | Buy |
3,793,300
+3,065
| +0.1% | +$12.7K | 0.02% | 758 |
|
|
2022
Q1 | $22M | Buy |
3,790,235
+202,865
| +6% | +$1.18M | 0.02% | 726 |
|
|
2021
Q4 | $26.9M | Sell |
3,587,370
-1,225
| -0% | -$9.19K | 0.01% | 691 |
|
|
2021
Q3 | $32.3M | Sell |
3,588,595
-8,956
| -0.2% | -$80.7K | 0.02% | 622 |
|
|
2021
Q2 | $43.1M | Buy |
3,597,551
+7,816
| +0.2% | +$93.6K | 0.02% | 566 |
|
|
2021
Q1 | $45M | Buy |
3,589,735
+181,749
| +5% | +$2.28M | 0.02% | 563 |
|
|
2020
Q4 | $53.2M | Buy |
3,407,986
+362,960
| +12% | +$5.66M | 0.03% | 483 |
|
|
2020
Q3 | $28.8M | Buy |
3,045,026
+136,385
| +5% | +$1.29M | 0.02% | 615 |
|
|
2020
Q2 | $26.1M | Buy |
2,908,641
+152,031
| +6% | +$1.36M | 0.02% | 630 |
|
|
2020
Q1 | $17.6M | Buy |
2,756,610
+282,422
| +11% | +$1.8M | 0.02% | 717 |
|
|
2019
Q4 | $20.7M | Buy |
2,474,188
+5,247
| +0.2% | +$43.9K | 0.02% | 749 |
|
|
2019
Q3 | $22.3M | Buy |
2,468,941
+104,529
| +4% | +$946K | 0.02% | 644 |
|
|
2019
Q2 | $25.5M | Buy |
2,364,412
+18,068
| +0.8% | +$195K | 0.02% | 602 |
|
|
2019
Q1 | $22.4M | Buy |
2,346,344
+1,201
| +0.1% | +$11.5K | 0.02% | 630 |
|
|
2018
Q4 | $26.9M | Buy |
2,345,143
+160,638
| +7% | +$1.84M | 0.03% | 515 |
|
|
2018
Q3 | $37M | Buy |
2,184,505
+415,764
| +24% | +$7.05M | 0.03% | 462 |
|
|
2018
Q2 | $25.1M | Sell |
1,768,741
-165,924
| -9% | -$2.36M | 0.02% | 602 |
|
|
2018
Q1 | $36.8M | Buy |
1,934,665
+1,292,860
| +201% | +$24.6M | 0.03% | 480 |
|
|
2017
Q4 | $10.5M | Buy |
641,805
+217,950
| +51% | +$3.57M | 0.01% | 1011 |
|
|
2017
Q3 | $6.36M | Buy |
423,855
+47,167
| +13% | +$708K | 0.01% | 1295 |
|
|
2017
Q2 | $3.32M | Buy |
376,688
+13,410
| +4% | +$118K | ﹤0.01% | 1585 |
|
|
2017
Q1 | $1.89M | Sell |
363,278
-9,490
| -3% | -$49.3K | ﹤0.01% | 2067 |
|
|
2016
Q4 | $1.14M | Sell |
372,768
-26,245
| -7% | -$80.1K | ﹤0.01% | 2599 |
|
|
2016
Q3 | $1.85M | Buy |
399,013
+3,069
| +0.8% | +$14.2K | ﹤0.01% | 2152 |
|
|
2016
Q2 | $2.29M | Buy |
395,944
+30,324
| +8% | +$176K | ﹤0.01% | 1991 |
|
|
2016
Q1 | $2.21M | Buy |
365,620
+54,420
| +17% | +$329K | ﹤0.01% | 1899 |
|
|
2015
Q4 | $2.84M | Sell |
311,200
-3,221
| -1% | -$29.4K | ﹤0.01% | 1877 |
|
|
2015
Q3 | $1.77M | Sell |
314,421
-98,515
| -24% | -$556K | ﹤0.01% | 2179 |
|
|
2015
Q2 | $4.58M | Buy |
412,936
+86,141
| +26% | +$955K | ﹤0.01% | 1649 |
|
|
2015
Q1 | $5.13M | Sell |
326,795
-49,223
| -13% | -$772K | 0.01% | 1480 |
|
|
2014
Q4 | $5.72M | Buy |
376,018
+80,361
| +27% | +$1.22M | 0.01% | 1429 |
|
|
2014
Q3 | $3.19M | Buy |
295,657
+153,296
| +108% | +$1.65M | ﹤0.01% | 1819 |
|
|
2014
Q2 | $2.17M | Sell |
142,361
-34,162
| -19% | -$522K | ﹤0.01% | 2281 |
|
|
2014
Q1 | $3.19M | Buy |
176,523
+128,265
| +266% | +$2.32M | ﹤0.01% | 1873 |
|
|
2013
Q4 | $669K | Sell |
48,258
-15,330
| -24% | -$213K | ﹤0.01% | 3170 |
|
|
2013
Q3 | $667K | Buy |
63,588
+30,877
| +94% | +$324K | ﹤0.01% | 2894 |
|
|
2013
Q2 | $256K | Buy |
+32,711
| New | +$256K | ﹤0.01% | 3333 |
|